284 related articles for article (PubMed ID: 22552254)
21. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
Lesca G; Olivieri C; Burnichon N; Pagella F; Carette MF; Gilbert-Dussardier B; Goizet C; Roume J; Rabilloud M; Saurin JC; Cottin V; Honnorat J; Coulet F; Giraud S; Calender A; Danesino C; Buscarini E; Plauchu H;
Genet Med; 2007 Jan; 9(1):14-22. PubMed ID: 17224686
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.
Bayrak-Toydemir P; McDonald J; Markewitz B; Lewin S; Miller F; Chou LS; Gedge F; Tang W; Coon H; Mao R
Am J Med Genet A; 2006 Mar; 140(5):463-70. PubMed ID: 16470787
[TBL] [Abstract][Full Text] [Related]
25. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.
Letteboer TG; Mager JJ; Snijder RJ; Koeleman BP; Lindhout D; Ploos van Amstel JK; Westermann CJ
J Med Genet; 2006 Apr; 43(4):371-7. PubMed ID: 16155196
[TBL] [Abstract][Full Text] [Related]
26. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
[TBL] [Abstract][Full Text] [Related]
27. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.
Fontalba A; Fernandez-L A; García-Alegria E; Albiñana V; Garrido-Martin EM; Blanco FJ; Zarrabeitia R; Perez-Molino A; Bernabeu-Herrero ME; Ojeda ML; Fernandez-Luna JL; Bernabeu C; Botella LM
BMC Med Genet; 2008 Aug; 9():75. PubMed ID: 18673552
[TBL] [Abstract][Full Text] [Related]
28. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
[TBL] [Abstract][Full Text] [Related]
29. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
30. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
[TBL] [Abstract][Full Text] [Related]
31. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
Govani FS; Shovlin CL
Eur J Hum Genet; 2009 Jul; 17(7):860-71. PubMed ID: 19337313
[TBL] [Abstract][Full Text] [Related]
32. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
[TBL] [Abstract][Full Text] [Related]
33. [Hereditary hemorrhagic telangiectasia].
Duffau P; Lazarro E; Viallard JF
Rev Med Interne; 2014 Jan; 35(1):21-7. PubMed ID: 23517771
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
[TBL] [Abstract][Full Text] [Related]
35. [Rendu-Osler disease: clinical and molecular update].
Bailly S; Dupuis-Girod S; Plauchu H
Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.
Letteboer TG; Mager HJ; Snijder RJ; Lindhout D; Ploos van Amstel HK; Zanen P; Westermann KJ
Am J Med Genet A; 2008 Nov; 146A(21):2733-9. PubMed ID: 18831062
[TBL] [Abstract][Full Text] [Related]
37. [Hereditary hemorrhagic telangiectasia. Report of a pediatric case].
Maaloul I; Aloulou H; Fourati H; Sfaihi L; Chabchoub I; Kamoun T; Mnif Z; Hachicha M
Arch Pediatr; 2014 Jul; 21(7):768-71. PubMed ID: 24935454
[TBL] [Abstract][Full Text] [Related]
38. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.
Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G
Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756
[TBL] [Abstract][Full Text] [Related]
39. Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Kim YH; Kim MJ; Choe SW; Sprecher D; Lee YJ; P Oh S
J Thromb Haemost; 2017 Jun; 15(6):1095-1102. PubMed ID: 28339142
[TBL] [Abstract][Full Text] [Related]
40. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.
Kjeldsen AD; Møller TR; Brusgaard K; Vase P; Andersen PE
J Intern Med; 2005 Oct; 258(4):349-55. PubMed ID: 16164574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]